Glenmede Trust’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.15M | Buy |
6,647
+68
| +1% | +$34.2K | 0.02% | 505 |
|
|
2025
Q4 | $3.07M | Buy |
+6,579
| New | +$3.05M | 0.01% | 504 |
|
|
2025
Q1 | $1.18M | Buy |
3,424
+208
| +6% | +$66.9K | 0.01% | 656 |
|
|
2024
Q4 | $965K | Buy |
3,216
+194
| +6% | +$67.8K | ﹤0.01% | 725 |
|
|
2024
Q3 | $1.23M | Buy |
3,022
+128
| +4% | +$46.9K | 0.01% | 665 |
|
|
2024
Q2 | $930K | Buy |
2,894
+133
| +5% | +$43.2K | ﹤0.01% | 709 |
|
|
2024
Q1 | $921K | Buy |
2,761
+254
| +10% | +$77.6K | ﹤0.01% | 730 |
|
|
2023
Q4 | $679K | Sell |
2,507
-39
| -2% | -$9.64K | ﹤0.01% | 808 |
|
|
2023
Q3 | $626K | Buy |
2,546
+191
| +8% | +$52.3K | ﹤0.01% | 775 |
|
|
2023
Q2 | $621K | Hold |
2,355
| – | – | ﹤0.01% | 778 |
|
|
2023
Q1 | $621K | Buy |
2,355
+74
| +3% | +$18.8K | ﹤0.01% | 780 |
|
|
2022
Q4 | $547K | Buy |
2,281
+600
| +36% | +$134K | ﹤0.01% | 814 |
|
|
2022
Q3 | $308K | Buy |
+1,681
| New | +$335K | ﹤0.01% | 947 |
|
|
2022
Q2 | – | Sell |
-1,305
| Closed | -$327K | – | 1326 |
|
|
2022
Q1 | $327K | Sell |
1,305
-19
| -1% | -$4.77K | ﹤0.01% | 1011 |
|
|
2021
Q4 | $340K | Buy |
1,324
+286
| +28% | +$70K | ﹤0.01% | 1016 |
|
|
2021
Q3 | $251K | Sell |
1,038
-516
| -33% | -$126K | ﹤0.01% | 1078 |
|
|
2021
Q2 | $320K | Buy |
1,554
+107
| +7% | +$21.8K | ﹤0.01% | 1013 |
|
|
2021
Q1 | $272K | Buy |
+1,447
| New | +$255K | ﹤0.01% | 991 |
|
|
2020
Q4 | – | Sell |
-824
| Closed | -$102K | – | 1653 |
|
|
2020
Q3 | $102K | Buy |
824
+82
| +11% | +$10.2K | ﹤0.01% | 1164 |
|
|
2020
Q2 | $72K | Sell |
742
-851
| -53% | -$88.5K | ﹤0.01% | 1234 |
|
|
2020
Q1 | $235K | Hold |
1,593
| – | – | ﹤0.01% | 1142 |
|
|
2019
Q4 | $235K | Sell |
1,593
-56
| -3% | -$7.52K | ﹤0.01% | 1142 |
|
|
2019
Q3 | $198 | Sell |
1,649
-140
| -8% | -$18.1K | ﹤0.01% | 1169 |
|
|
2019
Q2 | $241 | Sell |
1,789
-2,828
| -61% | -$358K | ﹤0.01% | 1103 |
|
|
2019
Q1 | $601 | Buy |
4,617
+2,812
| +156% | +$378K | ﹤0.01% | 847 |
|
|
2018
Q4 | $223 | Buy |
1,805
+531
| +42% | +$71.3K | ﹤0.01% | 1075 |
|
|
2018
Q3 | $176K | Buy |
1,274
+793
| +165% | +$98.7K | ﹤0.01% | 1187 |
|
|
2018
Q2 | $49K | Sell |
481
-3,000
| -86% | -$304K | ﹤0.01% | 1452 |
|
|
2018
Q1 | $304K | Hold |
3,481
| – | – | ﹤0.01% | 1052 |
|
|
2017
Q4 | $304K | Sell |
3,481
-181,917
| -98% | -$14.6M | ﹤0.01% | 1052 |
|
|
2017
Q3 | $14.8M | Sell |
185,398
-164,963
| -47% | -$13.3M | 0.06% | 329 |
|
|
2017
Q2 | $31.2M | Hold |
350,361
| – | – | 0.15% | 221 |
|
|
2017
Q1 | $31.2M | Buy |
350,361
+125,969
| +56% | +$10.5M | 0.15% | 221 |
|
|
2016
Q4 | $16.6M | Buy |
224,392
+195,604
| +679% | +$14.6M | 0.09% | 313 |
|
|
2016
Q3 | $2.18M | Sell |
28,788
-21,450
| -43% | -$1.64M | 0.01% | 612 |
|
|
2016
Q2 | $3.87M | Buy |
50,238
+41,541
| +478% | +$3.28M | 0.02% | 497 |
|
|
2016
Q1 | $678K | Sell |
8,697
-609
| -7% | -$42.5K | ﹤0.01% | 824 |
|
|
2015
Q4 | $629K | Sell |
9,306
-31,267
| -77% | -$2.18M | ﹤0.01% | 851 |
|
|
2015
Q3 | $3.14M | Sell |
40,573
-1,890
| -4% | -$167K | 0.02% | 490 |
|
|
2015
Q2 | $3.85M | Buy |
42,463
+20,534
| +94% | +$1.65M | 0.03% | 438 |
|
|
2015
Q1 | $1.65M | Sell |
21,929
-9,875
| -31% | -$709K | 0.01% | 640 |
|
|
2014
Q4 | $2.33M | Buy |
31,804
+31,082
| +4,305% | +$2.18M | 0.02% | 532 |
|
|
2014
Q3 | $50K | Buy |
722
+27
| +4% | +$1.78K | ﹤0.01% | 1688 |
|
|
2014
Q2 | $39K | Sell |
695
-815
| -54% | -$43K | ﹤0.01% | 1699 |
|
|
2014
Q1 | $78K | Sell |
1,510
-735
| -33% | -$36.6K | ﹤0.01% | 1513 |
|
|
2013
Q4 | $106K | Buy |
2,245
+1,730
| +336% | +$80K | ﹤0.01% | 1385 |
|
|
2013
Q3 | $22K | Buy |
515
+405
| +368% | +$15.8K | ﹤0.01% | 1787 |
|
|
2013
Q2 | $3K | Buy |
+110
| New | +$4.25K | ﹤0.01% | 2059 |
|
Other funds holding HCA
VCM
VPM
Glenmede Trust's HCA Position: Q1 2026 in Review
Glenmede Trust increased its HCA Healthcare (HCA) stake by 1% in Q1 2026, buying an estimated $34.2K and bringing the position to 6,647 shares worth $3.15M. The position accounts for 0.02% of the portfolio, ranked #505.
Glenmede Trust first reported a position in HCA in Q2 2013 and has held it in 48 quarters since. The position peaked at $31.2M in Q2 2017. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.
- Glenmede Trust held 6,647 shares of HCA Healthcare worth $3.15M as of Q1 2026.
- Glenmede Trust bought 68 HCA Healthcare shares in Q1 2026, an estimated $34.2K.
- HCA Healthcare made up 0.02% of Glenmede Trust's portfolio in Q1 2026, its #505 holding.
- Glenmede Trust first reported a position in HCA Healthcare in Q2 2013 and has held it in 48 quarters since.
- Glenmede Trust's HCA Healthcare position peaked at $31.2M in Q2 2017.
- 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.
Based on Glenmede Trust's 13F filing for Q1 2026, filed 26 May 2026.